Information needs and experiences from pregnancies complicated by hypertensive disorders: a qualitative analysis of narrative responses

Raj Shree, Kendra Hatfield-Timajchy, Alina Brewer, Eleni Tsigas, Marianne Vidler, Raj Shree, Kendra Hatfield-Timajchy, Alina Brewer, Eleni Tsigas, Marianne Vidler

Abstract

Background: Incorporation of the patient voice is urgently needed in a broad array of health care settings, but it is particularly lacking in the obstetrical literature. Systematically derived information about patients' experience with hypertensive disorders of pregnancy (HDP), most notably preeclampsia, is necessary to improve patient-provider communication and ultimately inform patient-centered care and research. We sought to examine the information needs and experiences of individuals with pregnancies complicated by hypertensive disorders.

Methods: We conducted a qualitative content analysis of narrative-responses to an open-ended question from the Preeclampsia Registry (TPR), an online registry hosted by the Preeclampsia Foundation. Individuals were invited to enroll in TPR via social media, web searches, and newsletters. We restricted our analysis to participants who self-reported a history of HDP and responded to the open-ended question, "Is there any information that you could have had at the time of this pregnancy that would have been helpful?". Available responses from July 2013 to March 2017 were included. Narrative responses were coded, reconciled, and thematically analyzed by multiple coders using an inductive approach. Our main outcome measures included participants' expressed needs and additional concerns with respect to their HDP pregnancy.

Results: Of 3202 enrolled participants, 1850 completed the survey and self-reported having at least one pregnancy complicated by HDP, of which 895 (48.4%) responded to the open-ended question. Participants delivered in the United States (83%) and 27 other countries. Compared to non-responders, responders reported more severe HDP phenotypes and adverse offspring outcomes. We identified three principal themes from responses: patient-identified needs, management and counseling, and potential action. Responses revealed that participants' baseline understanding of HDP, including symptoms, management, therapeutic strategies, and postpartum complications, was demonstrably lacking. Responders strongly desired improved counseling so that both they and their providers could collaboratively diagnose, appropriately manage, and robustly and continuously communicate to facilitate a partnership to address any HDP complications.

Conclusions: Participants' responses regarding their HDP experience provide indispensable insight into the patient's perspectives. Our study suggests that improved education regarding possible HDP complications and transparency about the consideration of HDP and its associated outcomes during an evaluation are needed, and efforts to implement these strategies should be sought.

Trial registration: The Preeclampsia Registry: NCT02020174.

Keywords: Hypertensive disorders of pregnancy; Patient experience; Preeclampsia; Qualitative research.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Flowchart of the identified themes and subthemes in our participant cohort
Fig. 2
Fig. 2
Flowchart demonstrating the study population. TPR, The Preeclampsia Registry; HDP, hypertensive disorders of pregnancy. *, Includes preeclampsia, eclampsia, HELLP syndrome, and chronic hypertension. Also included are participants who indicated having an HDP pregnancy but were unsure of their ultimate diagnosis or did not indicate a specific HDP diagnosis

References

    1. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. doi: 10.1097/01.AOG.0000437382.03963.88.
    1. Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, So AP. Critical care in obstetrical patients: an eight-year review. Chin Med J. 1997;110(12):936–941.
    1. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99(7):547–553. doi: 10.1111/j.1471-0528.1992.tb13818.x.
    1. Duley L. The global impact of pre-eclampsia and Eclampsia. Semin Perinatol. 2009;33(3):130–137.
    1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000 Jul;183(1):S1–22.
    1. Centers for Disease Control and Prevention. Data on selected pregnancy complications in the United States. [Internet]. 2019 [cited 2021 May 10]. Available from:
    1. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–1306. doi: 10.1097/AOG.0b013e3181a45b25.
    1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564. doi: 10.1136/bmj.f6564.
    1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7. doi: 10.1016/j.ejogrb.2013.05.005.
    1. Dolea, Carmen, Abou Zahr Carla. Global burden of hypertensive disorders of pregnancy in the year 2000. Evidence and information for policy (EIP), World Health Organization 2003 Jul;
    1. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1–19. doi: 10.1007/s10654-013-9762-6.
    1. Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139(8):1069–1079. doi: 10.1161/CIRCULATIONAHA.118.036748.
    1. Jansen MA, Pluymen LP, Dalmeijer GW, Groenhof TKJ, Uiterwaal CS, Smit HA, et al. Hypertensive disorders of pregnancy and cardiometabolic outcomes in childhood: a systematic review. Eur J Prev Cardiol. 2019;27:2047487319852716.
    1. Beukers F, Rotteveel J, Ganzevoort W, van Weissenbruch MM, van Goudoever JB, van Wassenaer-Leemhuis AG. Blood pressure of 12-year-old children born after foetal growth restriction due to hypertensive disorders of pregnancy; relation to neonatal, life style, and family characteristics. Early Hum Dev. 2019;130:33–37. doi: 10.1016/j.earlhumdev.2019.01.001.
    1. Pijnenborg R, Vercruysse L, Hanssens M. Fetal-maternal conflict, trophoblast invasion, preeclampsia, and the red queen. Hypertens Pregnancy. 2008;27(2):183–196. doi: 10.1080/10641950701826711.
    1. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243–1249. doi: 10.1161/01.HYP.0000188408.49896.c5.
    1. Duffy J, Thompson T, Hinton L, Salinas M, McManus RJ, Ziebland S, et al. What outcomes should researchers select, collect and report in pre-eclampsia research? A qualitative study exploring the views of women with lived experience of pre-eclampsia. BJOG. 2019;126(5):637–646. doi: 10.1111/1471-0528.15616.
    1. Tsigas E, Magee LA. Advocacy organisations as partners in pre-eclampsia progress: patient involvement improves outcomes. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):523–536. doi: 10.1016/j.bpobgyn.2011.03.001.
    1. Preeclampsia Registry [Internet]. [cited 2017 Mar 31]. Available from:
    1. Berry LL, Danaher TS, Beckham D, Awdish RLA, Mate KS. When patients and their families feel like hostages to health care. Mayo Clin Proc. 2017;92(9):1373–1381. doi: 10.1016/j.mayocp.2017.05.015.
    1. Joshi A, Beyuo T, Oppong S, Owusu A, Moyer C, Lawrence E. Exploring self-blame and the perceived causes of preeclampsia in urban Ghana. Int J Gynecol Obstet. 2020;29:152.
    1. Wilkinson J, Cole G. Preeclampsia knowledge among women in Utah. Hypertension in Pregnancy. 2018;37(1):18–24. doi: 10.1080/10641955.2017.1397691.
    1. You WB, Wolf M, Bailey SC, Pandit AU, Waite KR, Sobel RM, et al. Factors associated with patient understanding of preeclampsia. Hypertension in Pregnancy. 2012;31(3):341–349. doi: 10.3109/10641955.2010.507851.
    1. ACOG Committee Opinion No. 587: Effective patient-physician communication. Obstet Gynecol. 2014 Feb;123(2 Pt 1):389–93.
    1. Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy. 2010;29(3):294–300. doi: 10.3109/10641950902777747.
    1. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206(6):470–475. doi: 10.1016/j.ajog.2011.09.002.
    1. Roberts JM, Hubel CA. Pregnancy: a screening test for later life cardiovascular disease. Womens Health Issues. 2010;20(5):304–307. doi: 10.1016/j.whi.2010.05.004.
    1. Seely EW, Tsigas E, Rich-Edwards JW. Preeclampsia and future cardiovascular disease in women: how good are the data and how can we manage our patients? Semin Perinatol. 2015;39(4):276–283. doi: 10.1053/j.semperi.2015.05.006.
    1. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation. 2011;123(11):1243–62.
    1. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918–930. doi: 10.1016/j.ahj.2008.06.042.
    1. Virani SS, Alvaro A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. heart disease and stroke statistics—2021 update. Circulation. 2021;143(8):e254–743.
    1. de Havenon A, Delic A, Stulberg E, Sheibani N, Stoddard G, Hanson H, et al. Association of Preeclampsia with Incident Stroke in later life among women in the Framingham heart study. JAMA Netw Open. 2021;4(4):e215077. doi: 10.1001/jamanetworkopen.2021.5077.
    1. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112(2 Pt 1):359–372. doi: 10.1097/AOG.0b013e3181801d56.
    1. Hjartardottir S, Leifsson BG, Geirsson RT, Steinthorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol. 2006;194(4):916–920. doi: 10.1016/j.ajog.2005.10.819.
    1. Pittara T, Vyrides A, Lamnisos D, Giannakou K. Pre-eclampsia and long-term health outcomes for mother and infant: an umbrella review. BJOG. 2021;27.
    1. Grob R, Darien G, Meyers D. Why physicians should Trust in Patients. JAMA. 2019;321(14):1347–1348. doi: 10.1001/jama.2019.1500.
    1. Pellegrini CA. Trust: the keystone of the patient-physician relationship. J Am Coll Surg. 2017;224(2):95–102. doi: 10.1016/j.jamcollsurg.2016.10.032.
    1. Shapiro J. Illness narratives: reliability, authenticity and the empathic witness. Med Humanit. 2011;37(2):68–72. doi: 10.1136/jmh.2011.007328.
    1. van Giezen AE, Arensman E, Spinhoven P, Wolters G. Consistency of memory for emotionally arousing events: a review of prospective and experimental studies. Clin Psychol Rev. 2005;25(7):935–953. doi: 10.1016/j.cpr.2005.04.011.
    1. Gammill HS, Chettier R, Brewer A, Roberts JM, Shree R, Tsigas E, et al. Cardiomyopathy and Preeclampsia. Circulation. 2018;138(21):2359–2366. doi: 10.1161/CIRCULATIONAHA.117.031527.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren